Slide Decks on Schizophrenia

Schizophrenia is a highly heterogeneous and chronic mental health disorder with variable onset, symptom patterns, and long-term outcomes. The onset of schizophrenia is thought to arise from the interaction between neurobiological vulnerability and environmental exposures during development. The disease course is often fluctuating, with episodic exacerbations and periods of remission.

Core symptom domains in schizophrenia include positive, negative, disorganization, cognitive, and affective. Cognitive impairment is highly prevalent in schizophrenia, including deficits in episodic memory, processing speed, verbal fluency, and attention, and is strongly linked to poor social and vocational outcomes. The disease is reportedly associated with >1.5 times the odds of comorbidities across multiple disease categories, and is linked to broad, multi‑system increases in natural‑cause mortality.

Our educational slide decks include a comprehensive range of topics within schizophrenia, from its definition to its global prevalence, its etiology, as well as complex neurobiology. The many diverse comorbidities of schizophrenia, its course and prognosis, and treatment options are explained in depth. All our materials are developed by world-leading experts in the field and are available for free download and use in your teaching and other presentations.

History, Definitions, and Diagnosis

This educational slide deck explains the basic concepts and definitions related to schizophrenia and its diagnosis.

Distribution of schizophrenia costs

Epidemiology and Burden

The epidemiology and burden of schizophrenia slide deck includes illustrations and figures depicting the prevalence of the disease and the profound burden of it.

Aetiology and Neurobiology

This slide deck presents an introduction to the etiology of schizophrenia and the key mechanisms underlying the pathophysiology of the disease.

Course, Natural History and Prognosis

Schizophrenia course is often fluctuating, with episodic exacerbations and periods of remission. This slide deck provides an overview of the course and prognosis of the disorder.

Slide showing one slide from schizophrenia comorbidities slide deck

Comorbidities

This slide deck discusses psychiatric and somatic comorbidities, elevated mortality, and quality of life of people living with schizophrenia. Health inequities and preventive care gaps in schizophrenia are also introduced.

Treatment Principles

Different phases of schizophrenia have different treatment goals. This slide deck covers the acute and maintenance treatment of schizophrenia as well as how to approach non-response to the first antipsychotic and treatment resistance.


Articles on Schizophrenia

Schizophrenia is a highly heterogeneous disorder with variable onset, fluctuating symptom patterns, and difficult-to-predict long-term outcomes. Our expert-written articles provide an overview of a given topic, introducing you to the state-of-the-art research in an easy-to-read format. You can download the PDF versions of all our articles on the corresponding article page.


Watch the Videos on Schizophrenia

Schizophrenia is a chronic mental health disorder with positive, negative, motor symptoms, and cognitive deficits. In 2019, it was the 20th leading cause of disability worldwide, reducing life expectancy by over 15 years. It is a complex, heterogeneous disorder with multifactorial causes, including genetic and environmental factors and their interactions. Our expert videos explain this complex disorder in a clear, accessible manner.

Why is there a mortality gap in schizophrenia?

In this video, Professor Dr. Marco Solmi introduces what the mortality gap is and why there is a mortality gap in schizophrenia.

In this video, Professor Dr. Merete Nordentoft introduces her work with the population of children of parents with schizophrenia.

Can we help children at familial high-risk of schizophrenia?

In this video, Professor Dr. Merete Nordentoft introduces her work with the population of children of parents with schizophrenia.

Ana Catalan thumbnail

Is it possible to prevent psychotic disorders?

In this video, Professor Dr. Ana Catalan explores whether psychotic disorders can be prevented and reviews the latest evidence on early intervention in psychosis.

Diagnostic challenges and AI-augmented psychopathology

In this video, Professor Andrea Raballo argues that AI can reduce misdiagnosis and support earlier, more precise clinical decision-making.

How to treat schizophrenia?

In this video, Professor Dr. Stefan Leucht outlines four key recommendations for antipsychotic prescribing.

What is the aetiology of schizophrenia?

In this video, Professor Dr. Oliver Howes discusses the factors that make schizophrenia one of the most complex disorders in psychiatry.


Download Illustrations & Figures on Schizophrenia

Access images for use on Schizophrenia, including illustrations encompassing various aspects such as an overview of the global impact of schizophrenia, stages of biomarker discovery from target identification to clinical benefit verification, and exemplars of clinically valuable biomarkers in medical practice.


Frequently Asked Questions (FAQ)

The information provided in this document is for educational purposes only and is not a substitute for medical care. If you have questions about your health, speak with a healthcare professional.

Schizophrenia is a severe mental health condition that impacts a person’s thoughts, emotions, and behaviour. Those affected may appear disconnected from reality and behave in unusual ways, causing distress for them and/or family members, friends, and significant others. The condition’s symptoms can interfere with daily life and functioning, but effective treatment options are available.

References
  1. Neurotorium. Schizophrenia – History, Definitions, and Diagnosis. https://neurotorium.org/slidedeck/schizophrenia-history-definitions-diagnosis/
  2. Schizophrenia – National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/topics/schizophrenia.
  3. NHS Schizophrenia. nhs.uk https://www.nhs.uk/mental-health/conditions/ schizophrenia/overview/ (2023).

The exact cause of schizophrenia isn’t fully understood, but it’s believed to result from a combination of genetics, brain chemistry, and environmental factors. Risk is higher in people with a close relative with schizophrenia, and genetics have been estimated to account for up to 80% of the overall risk. Imbalances in neurotransmitters, such as dopamine and glutamate are also thought to play a role. Environmental factors, such as prenatal exposure to viruses, malnutrition, and a lack of oxygen during birth, may also contribute, as well as traumatic early life experiences, or drug abuse.

References
  1. Neurotorium. Schizophrenia – Aetiology and Neurobiology. https://neurotorium.org/slidedeck/schizophrenia-aetiology-and-neurobiology/
  2. Schizophrenia – National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/topics/schizophrenia.
  3. NHS Schizophrenia. nhs.uk https://www.nhs.uk/mental-health/conditions/ schizophrenia/overview/ (2023).
  4. WHO Schizophrenia. https://www.who.int/news-room/fact-sheets/detail/schizophrenia.

Schizophrenia impacts around 0.3% of people worldwide, while the lifetime risk of developing schizophrenia is often estimated at around 0.7%. It is not as common as many other mental disorders. The condition typically emerges in late adolescence or early adulthood, with men often experiencing onset earlier than women.

References
  1. Neurotorium. Schizophrenia – Epidemiology and Burden. https://neurotorium.org/slidedeck/schizophrenia-epidemiology-and-burden/
  2. WHO Schizophrenia. https://www.who.int/news-room/fact-sheets/detail/schizophrenia.
  3. Bhugra, D. The Global Prevalence of Schizophrenia. PLOS Med. 2, e151 (2005).
  4. Saha et al., A Systematic Review of the Prevalence of Schizophrenia. PLOS Med. 5, e141 (2005). DOI: 10.1371/journal.pmed.0020141

Schizophrenia symptoms are categorized as psychotic, negative, and cognitive:

Psychotic symptoms (also called “positive” symptoms because they are in addition compared to what people usually experience or display): Include hallucinations (e.g., hearing voices or seeing things that are not there), delusions (irrational beliefs, such as feeling persecuted or that one’s thoughts can be heard), disorganized thought (thinking or speech) or behavior (erratic or in severe cases immobility, or a general lack of response (“catatonia”). These symptoms disrupt perceptions of reality.

Negative symptoms (because they are less present or absent compared to what people usually experience or display): Include reduced motivation, emotional expression, speech, social interaction, and joy in things that the individual usually finds pleasurable, sometimes resembling depression.

Cognitive symptoms: Include impairments to memory, attention, and decision-making, as well as perception or interpretation of social context and interactions. These symptoms can make it hard to follow conversations, learn, or remember appointments or take medications as prescribed.

These symptoms can significantly impact daily life and functioning, but their severity varies across individuals and their illness stage. Proper evaluation and treatment can help manage these symptoms effectively.

References
  1. Neurotorium. Schizophrenia – Course, Natural History and Prognosis. https://neurotorium.org/slidedeck/schizophrenia-course-natural-history-prognosis/
  2. Schizophrenia – National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/topics/schizophrenia.
  3. NHS Schizophrenia. nhs.uk https://www.nhs.uk/mental-health/conditions/ schizophrenia/overview/ (2023).

Schizophrenia is diagnosed by a mental health professional based on a comprehensive assessment of symptoms, medical history, and sometimes a physical exam. The diagnosis typically follows criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) or International Classification of Diseases (ICD-10 or 11). Symptoms must persist for at least six months and interfere significantly with daily functioning. Often, the diagnosis also involves ruling out other mental health disorders or medical conditions that could cause similar symptoms.

References
  1. Neurotorium. Schizophrenia – History, Definitions, and Diagnosis. https://neurotorium.org/slidedeck/schizophrenia-history-definitions-diagnosis/
  2. Schizophrenia – National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/topics/schizophrenia.
  3. NHS Schizophrenia. nhs.uk https://www.nhs.uk/mental-health/conditions/ schizophrenia/overview/ (2023).
  4. Diagnostic and Statistical Manual of Mental Disorders (DSM) | Psychiatry Online. DSM Library https://www.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596

Schizophrenia is a chronic condition that requires long-term treatment. While there is no cure, people living with schizophrenia can lead fulfilling lives with proper treatment and support. Early intervention and continuous treatment can help manage symptoms, prevent relapses, and improve overall functioning.

Treatment for schizophrenia aims to manage symptoms, improve daily functioning, and help individuals achieve personal goals such as education, career development, and relationships. Care typically combines medications, psychotherapy, and support services. The shorter the untreated duration of psychosis is, the better the overall response, and successful early intervention programs have combined medication and non-medication treatments successfully.

Medications, particularly antipsychotics, can help reduce symptoms such as hallucinations and delusions and help to prevent relapses. Psychotherapy, such as cognitive-behavioural therapy (CBT), can help patients manage symptoms and improve coping skills. Family therapy, group therapy, and social skills training can enhance communication and relationship skills, as well as improve medication adherence and relapse prevention. Negative and cognitive symptoms are less treatable, but physical exercise, cognitive remediation, social skills training, and treatment of any comorbid depression can be helpful. Additionally, side effects of medications that can worsen negative and cognitive symptoms, such as sedation, muscle stiffness and marked weight gain, should be avoided or addressed as much as possible when they occur.

Support services, including psychosocial rehabilitation, help social integration and improve quality of life. Integrated treatment for substance use is also crucial, as substance misuse can hinder recovery. This multifaceted approach enables individuals to manage their condition and lead fulfilling lives.

References
  1. Neurotorium. Schizophrenia – Treatment Principles.https://neurotorium.org/slidedeck/schizophrenia-treatment-principles/
  2. Schizophrenia – National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/topics/schizophrenia.
  3. NHS Schizophrenia. nhs.uk https://www.nhs.uk/mental-health/conditions/ schizophrenia/overview/ (2023).
  4. WHO Schizophrenia. https://www.who.int/news-room/fact-sheets/detail/schizophrenia.
  5. Correll, C. U. et al. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Metaregression. JAMA Psychiatry 75, 555–565 (2018).
  6. Vita, A. et al. European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia. Eur. Psychiatry J. Assoc. Eur. Psychiatr. 65, e57 (2022).
  7. Galderisi, S. et al. EPA guidance on assessment of negative symptoms in schizophrenia. Eur. Psychiatry J. Assoc. Eur. Psychiatr. 64, e23 (2021).
  8. Carbon, M. & Correll, C. U. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia. CNS Spectr. 19 Suppl 1, 38–52; quiz 35–37, 53 (2014).

Supporting management and quality of life for someone living with schizophrenia involves understanding the condition and showing patience. Friends and family play an important role in providing both emotional and practical support. This can include monitoring mental health, recognising signs of relapse, and encouraging adherence to medication and attendance at medical appointments. Educating oneself about schizophrenia and connecting with support groups for families of people with schizophrenia can also be helpful strategies in supporting long-term management and quality of life.

Lifestyle strategies can also support the management of schizophrenia and improve overall quality of life. While lifestyle changes alone cannot treat schizophrenia, they can support well-being. Regular exercise, a healthy diet, and adequate sleep can help reduce stress, improve physical health, and may help improve cognitive symptoms. Avoiding substance and alcohol abuse is important, as substance use can worsen symptoms or trigger relapse. Building a strong support system and maintaining social connections within the community can also help individuals manage the challenges of living with schizophrenia.

References
  1. Neurotorium. Schizophrenia – Epidemiology and Burden. https://neurotorium.org/slidedeck/schizophrenia-epidemiology-and-burden/
  2. Vita, A. et al. European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia. Eur. Psychiatry J. Assoc. Eur. Psychiatr. 65, e57 (2022).
  • Antipsychotics: Medications that can minimise psychotic symptoms.
  • Catatonia: A condition characterized by extreme movement disturbances, including lack of movement, rigidity, or meaningless repetition of actions or words.
  • Cognitive-Behavioural Therapy: Therapy that targets unhelpful thoughts and behaviours to reduce distress and improve functioning.
  • Cognitive Remediation: A behavioural intervention that uses cognitive exercises and strategy coaching to improve skills like attention and memory, with the goal of enhancing everyday functioning.
  • Delusions: False beliefs that remain unchanged even when there is evidence to the contrary, such as believing one is being persecuted without any basis for this.
  • DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition): A manual used by healthcare professionals to diagnose mental health conditions, including schizophrenia.
  • Hallucinations: Sensory experiences that occur without real stimuli, such as hearing voices or seeing things that are not present.
  • ICD-11 (International Classification of Diseases, Eleventh Revision): A global standard for diagnosing health conditions and diseases, maintained by the World Health Organization.
  • Malnutrition: A state in which the body does not receive enough nutrients, leading to physical and mental health issues.
  • Psychotherapy: Treatment of mental disorders through conversations with a therapist to improve thoughts, feelings, and behaviours.
References
  1. Schizophrenia – National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/topics/schizophrenia.
  2. NHS Schizophrenia. nhs.uk https://www.nhs.uk/mental-health/conditions/ schizophrenia/overview/ (2023).
  3. Correll, C. U. et al. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Metaregression. JAMA Psychiatry 75, 555–565 (2018).

3D Brain Atlas

Neuroimaging findings consistently show brain structure abnormalities in schizophrenia:

  • Enlarged ventricles are reported in individuals with schizophrenia and are hypothesized to reflect surrounding tissue loss.
  • Lower grey matter volumes and reduced cortical thickness across multiple brain regions in individuals with schizophrenia versus controls.
  • Some evidence of increased volumes in striatal brain regions in individuals with schizophrenia, including the left and right putamen and right caudate.

Despite variable findings from individual studies, multimodal meta-analyses reveal convergence of neuroimaging abnormalities in a common network, associated with cortical thickness changes.1,2 Convergent abnormalities are mainly distributed in the anterior cingulum cortex, frontotemporal cortex, insula, striatum, and thalamus regions.1,2 Findings show cerebral abnormalities progress from the striatum to core cortical regions, before extending to widespread cortical and subcortical areas over the illness course.2